232 related articles for article (PubMed ID: 19308291)
21. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
Castillero E; Akashi H; Najjar M; Ji R; Brandstetter LM; Wang C; Liao X; Zhang X; Sperry A; Gailes M; Guaman K; Recht A; Schlosberg I; Sweeney HL; Ali ZA; Homma S; Colombo PC; Ferrari G; Schulze PC; George I
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H378-H390. PubMed ID: 31886717
[TBL] [Abstract][Full Text] [Related]
22. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R
J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339
[TBL] [Abstract][Full Text] [Related]
23. Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV.
Zhang HJ; Tai GX; Zhou J; Ma D; Liu ZH
World J Gastroenterol; 2007 Nov; 13(41):5501-5. PubMed ID: 17907296
[TBL] [Abstract][Full Text] [Related]
24. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
25. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
Lebrun JJ; Vale WW
Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
[TBL] [Abstract][Full Text] [Related]
26. An activin-A/C chimera exhibits activin and myostatin antagonistic properties.
Muenster U; Harrison CA; Donaldson C; Vale W; Fischer WH
J Biol Chem; 2005 Nov; 280(44):36626-32. PubMed ID: 16129674
[TBL] [Abstract][Full Text] [Related]
27. Identification of a binding site on the type II activin receptor for activin and inhibin.
Gray PC; Greenwald J; Blount AL; Kunitake KS; Donaldson CJ; Choe S; Vale W
J Biol Chem; 2000 Feb; 275(5):3206-12. PubMed ID: 10652306
[TBL] [Abstract][Full Text] [Related]
28. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
Renlund N; O'Neill FH; Zhang L; Sidis Y; Teixeira J
J Endocrinol; 2007 Oct; 195(1):95-103. PubMed ID: 17911401
[TBL] [Abstract][Full Text] [Related]
29. The rasGAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors.
Yamakawa N; Tsuchida K; Sugino H
EMBO J; 2002 Apr; 21(7):1684-94. PubMed ID: 11927552
[TBL] [Abstract][Full Text] [Related]
30. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis.
Chen YG; Wang Q; Lin SL; Chang CD; Chuang J; Ying SY
Exp Biol Med (Maywood); 2006 May; 231(5):534-44. PubMed ID: 16636301
[TBL] [Abstract][Full Text] [Related]
31. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Olsen OE; Wader KF; Hella H; Mylin AK; Turesson I; Nesthus I; Waage A; Sundan A; Holien T
Cell Commun Signal; 2015 Jun; 13():27. PubMed ID: 26047946
[TBL] [Abstract][Full Text] [Related]
32. Activin stimulates CYP19A gene expression in human ovarian granulosa cell-like KGN cells via the Smad2 signaling pathway.
Nomura M; Sakamoto R; Morinaga H; Wang L; Mukasa C; Takayanagi R
Biochem Biophys Res Commun; 2013 Jul; 436(3):443-8. PubMed ID: 23747729
[TBL] [Abstract][Full Text] [Related]
33. Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation.
Martins da Silva SJ; Bayne RA; Cambray N; Hartley PS; McNeilly AS; Anderson RA
Dev Biol; 2004 Feb; 266(2):334-45. PubMed ID: 14738881
[TBL] [Abstract][Full Text] [Related]
34. Identification of a functional binding site for activin on the type I receptor ALK4.
Harrison CA; Gray PC; Koerber SC; Fischer W; Vale W
J Biol Chem; 2003 Jun; 278(23):21129-35. PubMed ID: 12665502
[TBL] [Abstract][Full Text] [Related]
35. Activin signal transduction in the fetal rat adrenal gland and in human H295R cells.
Wang EY; Ma EY; Woodruff TK
J Endocrinol; 2003 Jul; 178(1):137-48. PubMed ID: 12844345
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the bone morphogenetic protein/receptor system during follicle development in the bovine ovary: Hormonal regulation of the expression of bone morphogenetic protein 7 (BMP-7) and its receptors (ActRII and ALK-2).
Shimizu T; Jayawardana BC; Nishimoto H; Kaneko E; Tetsuka M; Miyamoto A
Mol Cell Endocrinol; 2006 Apr; 249(1-2):78-83. PubMed ID: 16513253
[TBL] [Abstract][Full Text] [Related]
37. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
38. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
[TBL] [Abstract][Full Text] [Related]
39. Cycloheximide inhibits follicle-stimulating hormone β subunit transcription by blocking de novo synthesis of the labile activin type II receptor in gonadotrope cells.
Rejon CA; Ho CC; Wang Y; Zhou X; Bernard DJ; Hébert TE
Cell Signal; 2013 Jun; 25(6):1403-12. PubMed ID: 23499904
[TBL] [Abstract][Full Text] [Related]
40. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
